[Fibromyalgia syndrome].

Claudia Sommer

Abstract readEnglish AbstractReview

In one paragraph

Review in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Pectoralis Minor Tenotomy with Occasional Secondary Neurolysis Significantly Reduces Self-Reported Pain and Headaches Across Heterogenous Chronic Pain Disorders of the Upper Limb.Medicina (Kaunas, Lithuania) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Claudia SommerNeurologische Klinik und Poliklinik und Klinik und Poliklinik für Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie, Universitätsklinikum Würzburg, Straubmühlweg 2a, 97078, Würzburg, Deutschland. claudia.sommer@uni-wuerzburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibromyalgia syndrome (FMS) is a highly prevalent disorder that predominantly affects women. The absence of clear organ pathology and pathophysiology often leads to a lack of understanding towards those affected.

objectivesThis article aims to provide an overview of the definition, epidemiology, pathophysiology, and treatment options for FMS.

resultsFMS is defined as a syndrome characterized by chronic, multifocal pain lasting for at least 3 months, along with additional symptoms such as sleep disturbances, fatigue, or cognitive impairment. The prevalence in Germany is estimated to be approximately 2%. Risk factors may include genetics and epigenetics, childhood trauma, and adverse lifestyle factors. Pathophysiologically, alterations are found in the peripheral and central nervous systems, as well as in the endocrine and immune systems. Treatment focuses on non-pharmacological modalities such as physical therapy and psychological therapies, supplemented by medications such as amitriptyline, pregabalin, and duloxetine.

conclusionsFMS is a well-defined entity, but further research is needed to better understand the disorder and its subgroups and to develop causally oriented therapies.

Indexed as

FibromyalgiaFemaleGermanyHumansRisk FactorsChronic painDrug therapyFibromyalgia syndrome/multimodal treatmentPhysical therapyPsychotherapy

Identifiers

PMID41051502

DOI10.1007/s00108-025-01994-2

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.